AI trained to predict which skin cancers will spread
NCT ID NCT06327971
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a computer model that uses deep learning to analyze tissue samples from 300 people with a common skin cancer called squamous cell carcinoma. The goal is to see if the model can predict whether the cancer will spread to other parts of the body. No new drugs or treatments are being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a tool that helps doctors better predict which skin cancers might spread, improving follow-up care.
- What could go wrong
- This is an observational study using existing data, not a treatment trial. The model may not work as well in real-world settings or different patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE SKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Barts Health NHS Trust
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New radiation implant shows promise for skin cancer
- Mini-Device implanted in tumors could reveal which drug works best
- Glowing dots could help surgeons spot hidden cancer during surgery
- Sun simulator study seeks clues to skin cancer risk
- Radioactive bandage zaps skin cancer in early trial
- Danish study checks skin cancer patients years after radiation